home / stock / biov:cc / biov:cc news

BIOV:CC News and Press, Biovaxys Technology Corp.

Stock Information
Company Name: Biovaxys Technology Corp.
Stock Symbol: BIOV:CC
Market: CNQC
Website: biovaxys.com
Menu
BIOV:CC BIOV:CC Quote BIOV:CC Short BIOV:CC News BIOV:CC Articles BIOV:CC Message Board
Get BIOV:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
BIOV:CC - BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines

(TheNewswire)   VANCOUVER, BC and LANDERA RANCH, CA March 10 , 2026 -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:  BVAXF ) (" BioVaxys ") and Adiverna LLC (" Adiverna ") announce today that they have entered into a Research Agreement ("Agreement") ...
BIOV:CC - Canadian Companies Moving the Markets, Morning edition
Fri, Mar 06, 2026 as of 10.00 am ET

A look at the top 10 most actives in Canada The Canadian Chrome Company Subordinate Voting Shares (CACR) fell 25.0% to $0.015 on volume of 6,719,235 shares McFarlane Lake Mining Limited (MLM) rose 0.0% to $0.145 on volume of 4,802,002 shares Hydrograph Clean Power Inc. (HG) fell 7.0% to $7....

BIOV:CC - BioVaxys Announces Application for Management Cease Trade Order

(TheNewswire) Vancouver, BC – TheNewswire - March 3rd, 2026 – BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) (“ BioVaxys ” or the “ Company ”) announces that it was unable to file its annual financial statements, managemen...

BIOV:CC - Canadian Companies Moving the Markets, Morning edition
Tue, Feb 17, 2026 as of 10.00 am ET

A look at the top 10 most actives in Canada None (SPRK) rose 16.7% to $0.07 on volume of 10,494,603 shares The Canadian Chrome Company Subordinate Voting Shares (CACR) rose 0.0% to $0.015 on volume of 4,641,441 shares Giant Mining Corp. (BFG) fell 7.1% to $0.26 on volume of 3,531,677 shares...
BIOV:CC - Canadian Companies Moving the Markets, Morning edition
Fri, Feb 13, 2026 as of 10.00 am ET

A look at the top 10 most actives in Canada Global Li-Ion Graphite Corp. (LION) rose 100.0% to $0.03 on volume of 7,696,331 shares The Canadian Chrome Company Subordinate Voting Shares (CACR) rose 50.0% to $0.015 on volume of 5,327,600 shares American Pacific Mining Corp. (USGD) fell 2.8% t...

BIOV:CC - Canadian Companies Moving the Markets, Morning edition
Mon, Feb 02, 2026 as of 10.00 am ET

A look at the top 10 most actives in Canada Kuya Silver Corporation (KUYA) fell 1.1% to $0.93 on volume of 4,378,626 shares Ayurcann Holdings Corp. (AYUR) fell 66.7% to $0.005 on volume of 3,573,749 shares Vanguard Mining Corp. (UUU) rose 13.2% to $0.43 on volume of 3,531,856 shares Sanu ...

BIOV:CC - BioVaxys Reports Positive Phase 2 Data for Maveropepimut (MVP-S) + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer

(TheNewswire)   Reinforces Synergistic Potential and Expands Opportunity Beyond Ovarian Cancer   VANCOUVER, BC – TheNewswire - January 29, 2026 / TheNewswire / - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) (“BioVaxys" or the "Company"), a c...
BIOV:CC - BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)

Study subject Remains in Complete Response for 3 Years Exceeds Expectations in Platinum-Resistant Ovarian Cancer Compared to Standard of Care Single-Agent Chemotherapy Vancouver, British Columbia--(Newsfile Corp. - January 20, 2026) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB...

BIOV:CC - BioVaxys 1Q2026 R&D and Collaborative Activity

(TheNewswire)   VANCOUVER, BC, January 15 th ,2026/ - TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF ) ("BioVaxys" or the "Company") is pleased to provide an update on 1Q2026 initiatives, including collaborations and non-dilutive funding programs. Th...

BIOV:CC - BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

Vancouver, British Columbia--(Newsfile Corp. - January 8, 2026) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious disease, allergy, and other im...
Next 10